EryPed 200 - 0074-6302-13 - (Erythromycin Ethylsuccinate)

Alphabetical Index


Drug Information of EryPed 200

Product NDC: 0074-6302
Proprietary Name: EryPed 200
Non Proprietary Name: Erythromycin Ethylsuccinate
Active Ingredient(s): 200    mg/5mL & nbsp;   Erythromycin Ethylsuccinate
Administration Route(s): ORAL
Dosage Form(s): SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of EryPed 200

Product NDC: 0074-6302
Labeler Name: Abbott Laboratories
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050207
Marketing Category: NDA
Start Marketing Date: 20101201

Package Information of EryPed 200

Package NDC: 0074-6302-13
Package Description: 100 mL in 1 BOTTLE (0074-6302-13)

NDC Information of EryPed 200

NDC Code 0074-6302-13
Proprietary Name EryPed 200
Package Description 100 mL in 1 BOTTLE (0074-6302-13)
Product NDC 0074-6302
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Erythromycin Ethylsuccinate
Dosage Form Name SUSPENSION
Route Name ORAL
Start Marketing Date 20101201
Marketing Category Name NDA
Labeler Name Abbott Laboratories
Substance Name ERYTHROMYCIN ETHYLSUCCINATE
Strength Number 200
Strength Unit mg/5mL
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]

Complete Information of EryPed 200


General Information